Our Blog
Strong growth leads to strong stock performance.
Record revenue growth in 2020 pushed our shares higher and has Amyris positioned for another record year in 2021.
The Street
Our repositioning has sparked a surge in our stock price.
Refocusing Amyris on consumer products has our stock up 10-fold over the past year.
forbes
Vaccines can’t work without vials, needles and adjuvants.
Adjuvants like squalene that provoke the right immune response are a critical part of successful vaccines.
bloomberg
Covid-19 vaccines could further endanger sharks.
Squalene, found in shark livers, can make vaccines more effective. We’re producing a scalable and sustainable alternative.
National Geographic
Coronavirus vaccines spark debate about squalene.
Many coronavirus vaccines require squalene, which is naturally found in sharks and sustainably produced by Amyris.
New York Times
John Melo discusses Amyris growth and more.
CEO John Melo talks about the strong first quarter earnings report and our partnership with Ingredion.
Yahoo Finance
MAKE GOOD.
NO COMPROMISE.®
